EL
Elixxer Ltd.
ELIXF · OTC
$0.03 +0.00% (+$0.00)
Market Cap $4.44M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
57 /100
Average ROIC 380.10%
ROA 364.36%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.00x
Int. coverage -0.59x
Debt/Equity N/A
Stability
19 /100
Unstable Beta -0.54x
EPS volatility 49,036.32%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ELIXF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Karim Mecklai
Employees
0
Headquarters
Toronto
Nadcházející události
26 LIS
Earnings
Upcoming earnings report